Cambridge pipeline thin but high-value as lab-space squeeze tightens

Twelve applications were live with Greater Cambridge Shared Planning at the date of the briefing, none yet determined, carrying a combined estimated GDV of around £17m across 40 quantified units. The headline scheme is application 26/01691/REM, a reserved-matters submission for 425 residential units on land north of Cambridge North station off Milton Avenue (CB4 0AE), pursuant to the hybrid outline at 22/02771/OUT. That single application materially outweighs the rest of the live pipeline once approved, and its determination timetable is the most important planning event in the city this quarter. Beyond it, the recurring pattern is small-format. Application 26/01721/PRIOR proposes demolition of the EX1 building at Shepreth Research Park, Station Road, and a 25-flat replacement at a notional GDV of £8.1m, a textbook commercial-to-residential reprovision. Application 26/01684/PRIOR on Lensfield Road (CB2 1EN) proposes three Class E to C3 conversions on first and second floors, a small but indicative central change-of-use play. The rest of the list is dominated by single-dwelling self-build, demolition-rebuild and barn conversion proposals across Caldecote, Dudley Road, Adams Road, Fen Ditton and Gamlingay. Approval rate over the twelve-month window stands at zero in this dataset, but that reflects the pipeline being entirely undetermined rather than active refusals.

Land Registry data shows 953 completed transactions in Cambridge across the trailing twelve months, with median prices settling at £489,000 overall, £800,000 for detached, £560,000 for semi-detached, £496,250 for terraced and £320,000 for flats. The 32% new-build premium against existing stock is one of the steepest in the East of England and reflects how thinly newly-completed product is meeting demand: only 15 of the 953 transactions were new-build. Recent comparables from March 2026 confirm the spread. 53 Bishops Road (CB2 9NQ) sold for £951,200, 11 Plantation Avenue (CB2 9DL) for £980,000, and 29 Musgrave Drive (CB2 0AQ) for £830,000, anchoring the premium end. Mid-market is well represented by 51 Cromwell Road (CB1 3EB) at £515,100, 20 Water Street (CB4 1PA) at £600,000 and 14 Coniston Road (CB1 7BZ) at £525,000. Entry-level activity is dominated by leasehold flats, with 13 Gladeside (CB4 1EL) at £290,000 and Flat 9 Alder Court (CB4 1GX) at £150,000 illustrating the floor.

The Cambridge equation for developers is now a build-cost-versus-land-value squeeze. Site assembly costs remain elevated, build cost inflation has eased but not reversed, and exit prices have plateaued rather than risen, so the margin for error on appraisals is narrower than it has been in this cycle. Three plays look viable on current numbers. First, small-scale demolition-rebuild and self-build, where the developer effectively monetises the planning consent and avoids debt-heavy speculative builds: the Adams Road, Dudley Road and Caldecote applications all sit in this mould. Second, change-of-use and Class E to C3 conversions in central postcodes, like the Lensfield Road and Huntingdon Road schemes, where existing fabric reduces build cost per unit and central-Cambridge rents support exit value. Third, purpose-built student accommodation and co-living, where the structural undersupply of affordable graduate housing is not in dispute. Senior development finance on these sizes is typically pricing at 9-12% with gearing to around 65-70% LTGDV, with bridging from 0.65% per month covering site acquisition while planning runs.

The Q3 2026 picture turns on a single decision: the 425-unit Cambridge North reserved-matters application. Approval would shift the headline supply story overnight and free up confidence for further submissions in the same corridor. Without it, the pipeline reads as small, fragmented and dominated by self-build. Land values look set to hold, sold prices to drift sideways, and the binding constraint for developers will continue to be planning timetables rather than debt appetite. Lender sentiment toward Cambridge remains strong on residential, PBSA and lab-adjacent commercial, and well-presented schemes with realistic GDV assumptions should find competitive terms through the rest of 2026.